FDA inspection
Egis Pharmaceuticals PLC: FDA inspection ending Oct 12, 2000
FDA inspection 53324 · No Action Indicated (NAI) · Budapest
Key facts
| Inspection ID | 53324 |
|---|---|
| Firm | Egis Pharmaceuticals PLC |
| FEI number | 3002806880 |
| Address | Kereszturi Ut 30-38 |
| City | Budapest |
| Fiscal year | 2001 |
| Inspection end date | Oct 12, 2000 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|Generic Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data